Cargando…

Pseudohyperphosphatemia in a Patient with Multiple Myeloma

Hyperphosphatemia is an unusual manifestation in patients with multiple myeloma without a significantly reduced glomerular filtration rate. Serum phosphate may be falsely elevated when a large amount of paraproteins is present in the serum, because ultraviolet light absorbance is elevated with the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yonggu, Koo, Taiyon, Yi, Joo-Hark, Choi, Jung-Hye, Han, Sang-Woong, Park, Ile-Kyu, Kim, Ho-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Electrolyte and Blood Pressure Research 2007
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894513/ https://www.ncbi.nlm.nih.gov/pubmed/24459512 http://dx.doi.org/10.5049/EBP.2007.5.2.131

Ejemplares similares

Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013)

Pseudohyperphosphatemia in a patient with relapsed multiple myeloma after bone marrow transplantation: A case report
por: Kritmetapak, Kittrawee, et al.
Publicado: (2019)

Pseudohyperphosphatemia due to contamination with heparin: A case for caution
por: Senthilkumaran, S., et al.
Publicado: (2014)

Secondary Amyloidosis Associated with Multiple Sclerosis
por: Kang, Seok Jae, et al.
Publicado: (2009)

Recurrent Symptomatic Hyperglycemia on Maintenance Hemodialysis is not Necessarily Related to Hypertonicity : A Case Report
por: Park, Jae-Il, et al.
Publicado: (2008)

Icodextrin Improves the Serum Potassium Profile with the Enhancement of Nutritional Status in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Varying Dialysate Bicarbonate Concentrations in Maintenance Hemodialysis Patients Affect Post-dialysis Alkalosis but not Pre-dialysis Acidosis
por: Noh, U-Seok, et al.
Publicado: (2007)

Comparison of Icodextrin and 2.5% Glucose in Potassium Metabolism by Acute K(+) load via Dialysate in Continuous Ambulatory Peritoneal Dialysis Patients
por: Yi, Joo-Hark, et al.
Publicado: (2009)

Electrolyte Imbalances and Nephrocalcinosis in Acute Phosphate Poisoning on Chronic Type 1 Renal Tubular Acidosis due to Sjögren's Syndrome
por: Cho, Sung-Gun, et al.
Publicado: (2013)

Unintended Cannulation of the Subclavian Artery in a 65-Year-Old-Female for Temporary Hemodialysis Vascular Access: Management and Prevention
por: Choi, Jeong-Im, et al.
Publicado: (2012)

Does hypokalemia contribute to acute kidney injury in chronic laxative abuse?
por: Lee, Eun-Young, et al.
Publicado: (2015)

Cellular immunotherapy in multiple myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2019)

Development of objective indicators for quantitative analysis of sodium intake: the sodium to potassium ratio of second-void urine is correlated with 24-hour urinary sodium excretion
por: Kim, Jung Gon, et al.
Publicado: (2020)

Polyuria with the Concurrent manifestation of Central Diabetes Insipidus (CDI) & Type 2 Diabetes Mellitus (DM)
por: Shin, Hyun-Jong, et al.
Publicado: (2012)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Is There a Relationship between Hyperkalemia and Propofol?
por: Lee, Ju-Hyun, et al.
Publicado: (2011)

The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients
por: Jung, Joo Young, et al.
Publicado: (2014)

Incidental multiple myeloma in a patient with neuroretinitis: a case report
por: Joo, Taesung, et al.
Publicado: (2023)

Clinical Factors Associated with Brachial-Ankle Pulse Wave Velocity in Patients on Maintenance Hemodialysis
por: Kim, Eun-Young, et al.
Publicado: (2008)

Cancer incidence according to the National Health Information Database in Korean patients with end-stage renal disease receiving hemodialysis
por: Myung, Jisun, et al.
Publicado: (2020)

Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
por: Park, Man-Seok, et al.
Publicado: (2005)

Multiple Myeloma in a Patient with Acromegaly
por: Kang, Yu Mi, et al.
Publicado: (2015)

Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)

Unstable Pathologic Vertebral Fractures in Multiple Myeloma : Propensity Score Matched Cohort Study between Reconstructive Surgery with Adjuvant Radiotherapy and Radiotherapy Alone
por: Park, Hyung-Youl, et al.
Publicado: (2022)

Acute Pancreatitis in a Case of Multiple Myeloma with Hypercalcemia
por: Lee, Kyoo Hyung, et al.
Publicado: (1989)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

Continuous Multiple Vertebral Compression Fractures in Multiple Myeloma Patient
por: Hong, Sang Moon, et al.
Publicado: (2012)

A case of synchronous multiple myeloma and chronic myeloid leukemia
por: Lee, Ji-Young, et al.
Publicado: (2017)

Evaluation of changes in choroidal thickness and the choroidal vascularity index after hemodialysis in patients with end-stage renal disease by using swept-source optical coherence tomography
por: Shin, Yong Un, et al.
Publicado: (2019)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party
por: Jung, Sung-Hoon, et al.
Publicado: (2022)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Serum Parathyroid Hormone Is a New Potential Risk Factor in Multiple Myeloma
por: Kang, Min-Gu, et al.
Publicado: (2014)

Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone
por: Han, Sang Woong, et al.
Publicado: (2018)

Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient
por: Kang, Wonseok, et al.
Publicado: (2010)

Unusual Presentation of Multiple Myeloma
por: Jeon, Jeong Suk, et al.
Publicado: (2018)

Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience
por: Chong, Yong Pil, et al.
Publicado: (2008)

Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling
por: Heo, Sook-Kyoung, et al.
Publicado: (2022)

Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer
por: Kim, Nae Yu, et al.
Publicado: (2011)

A Case of Coincident Multiple Myeloma and Non-Hodgkin’s Lymphoma
por: Lee, Geun Chan, et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ig7e6kfvc2feu5hbgcumqbjmcs